Speaker illustration

Doctor Pam Taub

University of California San Diego, La Jolla (United States of America)

Pam R. Taub, MD is a board-certified cardiologist and founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center at UC San Diego. Her clinical practice focuses on preventive cardiology, lipidology, as well as women's cardiovascular health. Her research focuses on assessing the impact of behavioral, technological, and pharmacological interventions on cardiometabolic disease. Dr. Taub's is a federally funded researcher with funding from: the National Institutes of Health (Principal Investigator on R01 grant), Department of Defense, Department of Homeland Security and American Heart Association. She is an experienced clinical trialist and serves on the executive committee for multiple international clinical trials focused on novel cardiovascular therapies. Dr. Taub is widely published (with over 100 publications) and has authored high impact publications in top peer-reviewed journals that have impacted clinical practice.

Metabolic drivers of cardiovascular disease

Event: ESC Congress 2025

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session type: Abstract Sessions

Thumbnail

Late-Breaking Clinical Science: cardiometabolic medicine

Event: ESC Congress 2025

Topic: Risk Factors and Prevention

Session type: Late-Breaking Science

Thumbnail

Hypertension care, reimagined: The Symplicity blood pressure procedure

Event: ESC Congress 2025

Topic: Renal Denervation

Session type: Satellite Symposium

Thumbnail

Crossing boundaries: cholesteryl ester transfer protein (CETP) inhibitors and the next frontier in lipid control

Event: ESC Congress 2025

Topic: Lipids

Session type: Satellite Symposium

Thumbnail

Smaller trials and other studies on atherosclerosis

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session type: Late-Breaking Science

Thumbnail

Ask the Trialists from Hot Line 2

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session type: Ask the Trialists

Thumbnail

Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Event: ESC Congress 2023

Topic: Percutaneous Coronary Intervention (PCI)

Session type: Advances in Science

Thumbnail